Earli
Sushil Lathwal is a skilled professional in the field of bioengineering, currently serving as a Delivery Bioengineer at Earli Inc. since February 2022. Previously, Sushil held the position of Postdoctoral Researcher at the Massachusetts Institute of Technology from September 2020 to February 2022, working under the guidance of Professor Daniel G. Sushil's academic background includes a Doctor of Philosophy in Chemistry from Carnegie Mellon University, where research was conducted from 2014 to 2020 and guided by Professors Krzysztof Matyjaszewski and others. Additional research experience includes roles as a Graduate Student Researcher at Carnegie Mellon University, Undergraduate Researcher at IISER Bhopal, and summer internships at the Indian Institute of Technology, Guwahati, and IISER Bhopal, focusing on topics such as peptidic catalysts, molecular docking, and peptide synthesis.
This person is not in any teams
Earli
1 followers
Earli has an ambitious mission: to force cancer reveal its location at its earliest stages, which makes it quickly treatable. In other words, they aim to make cancer a benign experience. Their science is based on a new method of detecting, localizing and then treating cancer called "Synthetic Biopsies," originally developed by the late Dr. Sam Gambhir at Stanford.